Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- Nigeria4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,200 people enrolled
- Started
- 31 Oct 2023
- Ended
- 30 Nov 2024
- Type of study
- Observational, 4 groups
- Treatments tested
- Exposure of interest - Moderate or High-risk Preeclampsia
- Record updated
- 2 July 2025
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adult pregnant woman > 18 years old / emancipated pregnant minors (<18years), according to the stipulations of the Nigerian National Health Research Ethics Committee (NRHEC)
- >12 weeks' gestation attending antenatal care clinics on 2nd or subsequent visit
- Those presenting to the labor and delivery room
Who cannot take part
- Unable to provide consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study is to evaluate the use of aspirin for the prevention of preeclampsia among moderate -to- high-risk pregnant women in tertiary care hospitals in Nigeria followed by a qualitative study to evaluate the barriers and facilitators of aspirin use in prenatal care for the prevention of preeclampsia in Nigeria. The main question[s] it aims to answer are:
Read full original descriptionShow less
1. Is Aspirin used for the prevention of preeclampsia among pregnant women in Nigeria? 2. What factors promote or prevent the utilization of Aspirin for preeclampsia prevention among pregnant women in Nigeria.
The 4 groups in the trial
- University of Abuja Teaching Hospital
Pregnant women with Hypertensive Disorder of Pregnancy who seek care in the Federal Capital Territory, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.
Treatment: Exposure of interest - Moderate or High-risk Preeclampsia
- Amino Kano Teaching Hospital
Pregnant women with Hypertensive Disorder of Pregnancy who seek care in Kano State in Nigeria, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.
Treatment: Exposure of interest - Moderate or High-risk Preeclampsia
- National Hospital, Abuja
Pregnant women with Hypertensive Disorder of Pregnancy who seek care in the Federal Capital Territory, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.
Treatment: Exposure of interest - Moderate or High-risk Preeclampsia
- Murtala Muhammad Specialist Hospital
Pregnant women with Hypertensive Disorder of Pregnancy who seek care in Kano State in Nigeria, attending antenatal clinics on the 2nd or subsequent visit and pregnant women presenting to the labor and delivery room.
Treatment: Exposure of interest - Moderate or High-risk Preeclampsia
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 2 July 2025